NCT07015957

Brief Summary

The goal of this clinical trial is identify an effective and implementable set of implementation strategies to increase cervical cancer prevention in Malawi. The main questions it aims to answer are:

  1. 1.Which implementation strategies produce the greatest increase in provider recommendation for, and uptake of, cervical cancer prevention tools among people receiving HIV care.
  2. 2.What is the acceptability, appropriateness, feasibility, and cost of these implementation strategies.
  3. 3.What is the sustained effect of these implementation strategies. The implementation strategies will be conducted with health workers (clinical officers, nurses, and medical assistants): training, coaching, and a reminder system.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,000

participants targeted

Target at P75+ for phase_4

Timeline
40mo left

Started Jul 2025

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jul 2025Aug 2029

First Submitted

Initial submission to the registry

June 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

July 8, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2029

Last Updated

April 30, 2026

Status Verified

August 1, 2025

Enrollment Period

1.1 years

First QC Date

June 3, 2025

Last Update Submit

April 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in prevalence of discussions surrounding methods of cervical cancer prevention

    Discussions about methods of cervical cancer prevention will be reported by clients following each routine HIV care visit. This rate is defined as the percentage of visits during which there is a discussion about methods of cervical cancer prevention. This rate will be compared between the groups with and without each intervention component.

    Months 7-18

Secondary Outcomes (2)

  • Difference in prevalence of completing a cervical cancer prevention program

    Months 7-18

  • Difference in prevalence of initiating a cervical cancer prevention program among those uninitiated

    Months 7-18

Other Outcomes (1)

  • Acceptability of the implementation strategies

    Months 1-9

Study Arms (8)

Condition 1: In-person training

ACTIVE COMPARATOR
Behavioral: In-person training

Condition 2: In-person training + Prompt

EXPERIMENTAL
Behavioral: In-person trainingBehavioral: Prompts

Condition 3: In-person training + Coaching

EXPERIMENTAL
Behavioral: In-person trainingBehavioral: Coaching

Condition 4: In-person training + Prompt + Coaching

EXPERIMENTAL
Behavioral: In-person trainingBehavioral: CoachingBehavioral: Prompts

Condition 5: Virtual training

EXPERIMENTAL
Behavioral: Virtual training

Condition 6: Virtual training + Prompt

EXPERIMENTAL
Behavioral: Virtual trainingBehavioral: Prompts

Condition 7: Virtual training + Coaching

EXPERIMENTAL
Behavioral: Virtual trainingBehavioral: Coaching

Condition 8: Virtual training + Prompt + Coaching

EXPERIMENTAL
Behavioral: Virtual trainingBehavioral: CoachingBehavioral: Prompts

Interventions

PromptsBEHAVIORAL

Visual aide to remind providers to discuss cervical cancer prevention methods.

Condition 2: In-person training + PromptCondition 4: In-person training + Prompt + CoachingCondition 6: Virtual training + PromptCondition 8: Virtual training + Prompt + Coaching

An in-person educational session.

Condition 1: In-person trainingCondition 2: In-person training + PromptCondition 3: In-person training + CoachingCondition 4: In-person training + Prompt + Coaching

A virtual educational session.

Condition 5: Virtual trainingCondition 6: Virtual training + PromptCondition 7: Virtual training + CoachingCondition 8: Virtual training + Prompt + Coaching
CoachingBEHAVIORAL

Short video vignettes plus reinforcing messages

Condition 3: In-person training + CoachingCondition 4: In-person training + Prompt + CoachingCondition 7: Virtual training + CoachingCondition 8: Virtual training + Prompt + Coaching

Eligibility Criteria

Age9 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Health workers: People who provide medical care and counseling (typically medical assistants, clinical officers, and nurses), and interact with adolescent girls and young women aged 9-24 and/or their parents/caregivers.
  • Clients: Non-pregnant females aged 9-24 (for those aged 9-17, their male or female parent/guardian will also be eligible for participation) who present for HIV care at a participating health facility during the study period.

You may not qualify if:

  • Health workers: Less than 18 years of age, or not an active and regular provider of medical care or counseling at the facility, or unable or unwilling to provide informed consent.
  • Clients: \<9 or \>24 years old, or pregnancy, or unable or unwilling to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Partners in Hope

Lilongwe, Malawi

RECRUITING

Study Officials

  • Corrina Moucheraud

    New York University

    PRINCIPAL INVESTIGATOR
  • Risa M Hoffman

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • Sam Phiri

    Partners in Hope, Inc.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Corrina Moucheraud

CONTACT

Risa M Hoffman

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2025

First Posted

June 11, 2025

Study Start

July 8, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2029

Last Updated

April 30, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Fully deidentified survey data and focus group discussion transcripts

Shared Documents
STUDY PROTOCOL, ICF
Access Criteria
Survey data will be deposited into a data repository after it has been fully de-identified. De-identified focus group discussion data will be available on a by-request basis via a data repository.

Locations